DongKook Pharmaceutical Co. Ltd (086450) — Working Capital to Net Assets Ratio
DongKook Pharmaceutical Co. Ltd (086450) has a Working Capital to Net Assets ratio of 39.0% as of December 2025. Working capital of ₩297.98 Billion (current assets of ₩565.40 Billion minus current liabilities of ₩267.41 Billion) is measured against net assets of ₩763.74 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See DongKook Pharmaceutical Co. Ltd balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
DongKook Pharmaceutical Co. Ltd Working Capital to Net Assets (2014–2025)
This chart shows how DongKook Pharmaceutical Co. Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 39.0%, reflecting working capital of ₩297.98 Billion against net assets of ₩763.74 Billion KRW. Check DongKook Pharmaceutical Co. Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for DongKook Pharmaceutical Co. Ltd (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for DongKook Pharmaceutical Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is DongKook Pharmaceutical Co. Ltd worth.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 39.0% | ₩297.98 Billion | ₩763.74 Billion | ₩565.40 Billion | ₩267.41 Billion | ▲ +4.1 pp |
| 2024 | 35.0% | ₩237.31 Billion | ₩678.98 Billion | ₩470.01 Billion | ₩232.69 Billion | ▲ +2.3 pp |
| 2023 | 32.6% | ₩188.04 Billion | ₩576.17 Billion | ₩419.20 Billion | ₩231.15 Billion | ▼ -4.6 pp |
| 2022 | 37.2% | ₩186.78 Billion | ₩501.94 Billion | ₩385.32 Billion | ₩198.54 Billion | ▼ -6.8 pp |
| 2021 | 44.0% | ₩199.96 Billion | ₩454.57 Billion | ₩420.23 Billion | ₩220.27 Billion | ▼ -17.7 pp |
| 2020 | 61.7% | ₩253.80 Billion | ₩411.37 Billion | ₩398.76 Billion | ₩144.97 Billion | ▼ -1.4 pp |
| 2019 | 63.1% | ₩229.01 Billion | ₩362.87 Billion | ₩339.02 Billion | ₩110.01 Billion | ▼ -3.4 pp |
| 2018 | 66.5% | ₩208.06 Billion | ₩313.02 Billion | ₩300.43 Billion | ₩92.37 Billion | ▼ -5.9 pp |
| 2017 | 72.4% | ₩191.00 Billion | ₩263.94 Billion | ₩271.19 Billion | ₩80.18 Billion | ▲ +4.5 pp |
| 2016 | 67.9% | ₩161.11 Billion | ₩237.32 Billion | ₩233.99 Billion | ₩72.89 Billion | ▼ -0.4 pp |
| 2015 | 68.3% | ₩136.35 Billion | ₩199.62 Billion | ₩195.18 Billion | ₩58.83 Billion | ▲ +0.1 pp |
| 2014 | 68.2% | ₩120.39 Billion | ₩176.57 Billion | ₩173.16 Billion | ₩52.77 Billion | — |